Article
Examining the characteristics of the IgG antibody response generated during early HIV-1 infection using molecular cloning techniques
2018-01-01
Abstract excerpt
There is much interest in the possible use of broadly neutralising antibodies (BNAbs) isolated from chronically infected HIV-1 patients to reduce the HIV-1 latent reservoir and to serve as a tool in vaccine design. However, the RV144 trial, the only HIV vaccine efficacy trial to date to show any protection, has highlighted the potential importance of non-neutralising antibodies and IgG subclass in HIV-1 control, w...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 536acf2f-5fcc-50a5-8853-0670780f62f1
- DOI
- 10.25560/65741
